Company / Assets per Share
Viking Therapeutics, Inc. Assets per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$6.41
FY2025
5-year range
$2.15 / $9.07
FY2021-FY2025
Trend
-29.3%
vs FY2024
Sector context
#132 of 210
Health Care
What the data says
At $6.41, Viking Therapeutics, Inc.'s assets per share ranks #132 of 210 in the Health Care sector. Assets per Share has fluctuated over the past 10 years, ranging from $1.06 in FY2017 to $9.07 in FY2024.
Based on SEC 10-K filings.
6.41 in FY2025 with a 5-year CAGR of +12.6%.
Improved from $4.71 to $6.41 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- +43.9%
- 5-Year CAGR
- +12.6%
- 10-Year CAGR
- -
Sector benchmark
#132 of 210 in Health CareTop 63% of 210This company $6.41 Sector average $353.15
▼
-98.2% below sector average
Key checks
Key Insights
- In FY2025, assets per share decreased 29.3% year-over-year.
- Ranks #132 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2024.
- Lowest assets per share in the period was in FY2017.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $6.41 | -29.3% |
| FY2024 | $9.07 | +92.7% |
| FY2023 | $4.71 | +118.6% |
| FY2022 | $2.15 | -25.1% |
| FY2021 | $2.88 | -18.8% |
| FY2020 | $3.54 | -10.6% |
| FY2019 | $3.96 | -53.1% |
| FY2018 | $8.44 | +694.6% |
| FY2017 | $1.06 | -29.2% |
| FY2016 | $1.50 | -41.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026